Stock Analysis on Net

Baxter International Inc. (NYSE:BAX)

This company has been moved to the archive! The financial data has not been updated since August 4, 2016.

Enterprise Value to FCFF (EV/FCFF)

Microsoft Excel

Free Cash Flow to The Firm (FCFF)

Baxter International Inc., FCFF calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Net income attributable to Baxter 968 2,497 2,012 2,326 2,224
Net income attributable to noncontrolling interests 32
Net noncash charges 477 1,382 1,432 1,386 1,601
Changes in balance sheet items (316) (664) (246) (606) (1,040)
Cash flows from operations 1,129 3,215 3,198 3,106 2,817
Interest paid, net of portion capitalized, net of tax1 163 166 158 108 49
Interest costs capitalized, net of tax2 47 56 55 42 32
Capital expenditures (911) (1,898) (1,525) (1,161) (960)
Free cash flow to the firm (FCFF) 428 1,539 1,886 2,095 1,938

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

Item Description The company
FCFF Free cash flow to the firm is the cash flow available to the Baxter International Inc. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made. Baxter International Inc. FCFF decreased from 2013 to 2014 and from 2014 to 2015.

Interest Paid, Net of Tax

Baxter International Inc., interest paid, net of tax calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Effective Income Tax Rate (EITR)
EITR1 8.20% 20.20% 21.00% 20.00% 20.00%
Interest Paid, Net of Tax
Interest paid, net of portion capitalized, before tax 178 208 200 135 61
Less: Interest paid, net of portion capitalized, tax2 15 42 42 27 12
Interest paid, net of portion capitalized, net of tax 163 166 158 108 49
Interest Costs Capitalized, Net of Tax
Interest costs capitalized, before tax 51 70 70 52 40
Less: Interest costs capitalized, tax3 4 14 15 10 8
Interest costs capitalized, net of tax 47 56 55 42 32

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 See details »

2 2015 Calculation
Interest paid, net of portion capitalized, tax = Interest paid, net of portion capitalized × EITR
= 178 × 8.20% = 15

3 2015 Calculation
Interest costs capitalized, tax = Interest costs capitalized × EITR
= 51 × 8.20% = 4


Enterprise Value to FCFF Ratio, Current

Baxter International Inc., current EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Selected Financial Data (US$ in millions)
Enterprise value (EV) 25,328
Free cash flow to the firm (FCFF) 428
Valuation Ratio
EV/FCFF 59.15
Benchmarks
EV/FCFF, Competitors1
Abbott Laboratories 34.37
Cigna Group 10.88
CVS Health Corp. 11.30
Danaher Corp. 34.36
Elevance Health Inc. 14.87
Humana Inc. 8.61
Intuitive Surgical Inc. 167.73
Medtronic PLC 24.68
Shockwave Medical Inc. 72.49
UnitedHealth Group Inc. 17.36

Based on: 10-K (reporting date: 2015-12-31).

1 Click competitor name to see calculations.

If the company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if the company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.


Enterprise Value to FCFF Ratio, Historical

Baxter International Inc., historical EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Enterprise value (EV)1 20,781 43,675 44,093 38,961 34,243
Free cash flow to the firm (FCFF)2 428 1,539 1,886 2,095 1,938
Valuation Ratio
EV/FCFF3 48.53 28.38 23.38 18.60 17.67
Benchmarks
EV/FCFF, Competitors4
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
Shockwave Medical Inc.
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 See details »

2 See details »

3 2015 Calculation
EV/FCFF = EV ÷ FCFF
= 20,781 ÷ 428 = 48.53

4 Click competitor name to see calculations.

Valuation ratio Description The company
EV/FCFF Enterprise value to free cash flow to the firm is whole company valuation indicator. Baxter International Inc. EV/FCFF ratio increased from 2013 to 2014 and from 2014 to 2015.